Related Experiment Videos
Insights
This study found that vitamin E therapy did not significantly improve liver enzyme levels in children with viral hepatitis compared to no treatment. Further research is needed to explore potential benefits of vitamin E for pediatric liver conditions.
Area of Science:
- Pediatric Hepatology
- Nutritional Supplementation
- Viral Hepatitis Treatment
Background:
- Viral hepatitis in children can lead to significant liver inflammation.
- Vitamin E is an antioxidant with potential anti-inflammatory properties.
- Limited data exists on vitamin E efficacy in pediatric viral hepatitis.
Purpose of the Study:
- To evaluate the effectiveness of vitamin E therapy versus no treatment in children diagnosed with viral hepatitis.
- To assess the impact of vitamin E on key indicators of liver function.
Main Methods:
- A randomized, prospective trial was conducted.
- Two groups of children with viral hepatitis were compared: one receiving intramuscular vitamin E (300 mg/day for 7 days) and a control group receiving no treatment.
- Demographic data and serum liver enzyme levels (transaminases, alkaline phosphatase) were analyzed.
Main Results:
- The study groups were similar in mean age, sex ratio, and duration of illness.
- No statistically significant difference was observed in mean serum transaminases or alkaline phosphatase levels between the vitamin E treated group and the no treatment group.
Conclusions:
- Vitamin E therapy, administered intramuscularly for seven days, did not demonstrate a significant benefit in improving liver enzyme levels in children with viral hepatitis.
- The findings suggest that vitamin E may not be an effective treatment for viral hepatitis in this pediatric population under the studied conditions.
Abstract:
Vitamin E therapy was compared with no treatment in a randomized, prospective trial for treatment of viral hepatitis in children. Patients received either vitamin E. (n:21), 300 mg./day intramuscularly every 24 hours, for seven days, or no treatment (n:20). The mean age (6.6 and 6.2), sex ratio, and the mean duration of illness before administration to study of two groups were similar. No difference was noted in the mean serum transaminases and alkaline phosphatase levels between both groups.